Pressure-Treated Yeast Fiber Compounds May Benefit IPF Patients
![Feature image](https://healthsci.mcmaster.ca/wp-content/uploads/2023/07/pressure-treated-yeast-fiber-compounds-may-benefit-ipf-patients.png)
An inhalable therapeutic is being developed using pressure-treated yeast beta-glucan for people with COVID-19 as well as other severe lung diseases, including idiopathic pulmonary fibrosis (IPF) is being developed by Ceapro Inc. in collaboration with Drs. Kjetil Ask and Todd Hoare.
Related News
News Listing
![This composite image shows researchers Hong Han and Sheila Singh.](https://healthsci.mcmaster.ca/wp-content/uploads/2024/06/FHS24_CRC_Hong_Sheila_CC01.jpg)
Two Faculty of Health Sciences cancer researchers awarded Canada Research Chairs
Dept. Biochem, Dept. Surgery, Feature, Research
7 days ago
![Elena Verdu can be seen in this composite image. Verdu is smiling, wearing a green-coloured shirt and a necklace.](https://healthsci.mcmaster.ca/wp-content/uploads/2024/06/Elena-Verdu.jpg)
Elena Verdu appointed director of Farncombe Family Digestive Health Research Institute
Faculty & Staff, Research
7 days ago